编辑: 王子梦丶 2017-05-09
"附件1:" "2013年1月1日-2014年3月31日中标企业基本药物网上集中采购配送区域统计表" "中标企业","生产企业","识别码","通用名","剂型","规格","包装材质","包装数量","包装单位","药品通用名","实际规格","批准文号","转换系数","中标价","中标年份","药品类别","已选择配送区域详情","按品规统计已配送区域数","按品规统计未配送区域数","按企业统计未配送区域数","拟扣分","申诉核查后配送区域统计情况",,

,,

, 配送市州","配送区县","按品规计已配送区域","按品规计未配送区域","按企业计未配送区域","拟扣分" "阿特维斯(佛山)制药有限公司","阿特维斯(佛山)制药有限公司","34755","依那普利","胶囊剂","5mg",,

"20","瓶","马来酸依那普利胶囊","5mg","国药准字H10930089","20","10.

380009765625","2011","基药","省直属","1","14","14","-3",,

,,

,,

"安徽安科余良卿药业有限公司","安徽安科余良卿药业有限公司","32578","狗皮膏","膏药","12g",,

"1","袋","狗皮膏","12g","国药准字Z34020899","1","1.95000122070312","2011","基药","省直属","1","14","29","-3",,

,,

,,

"安徽安科余良卿药业有限公司","安徽安科余良卿药业有限公司","32578","狗皮膏","膏药","15g","复合塑料","10","盒","狗皮膏","15g","国药准字Z34020899","10","24","2013","基药",,

"0","15" "安徽宏业药业有限公司","安徽宏业药业有限公司","300234","缩宫素","注射液","5单位:1ml","其他","1","支","缩宫素注射液","1ml:5单位","国药准字H34022980","1","11.810009765625","2013","基药(仅限县级以上医疗机构采购)","省直属","1","14","14","-3",,

,,

,,

"安徽济人药业有限公司","安徽济人药业有限公司","302081","疏风解毒","胶囊剂","0.52g","铝塑泡罩包装","36","粒","疏风解毒胶囊","0.52g","国药准字Z20090047","36","42.1600390625","2013","基药",,

"0","15","28","-3",,

,,

,,

"安徽济人药业有限公司","安徽济人药业有限公司","300382","疏风解毒","胶囊剂","0.52g","铝塑泡罩包装","24","粒","疏风解毒胶囊","0.52g","国药准字Z20090047","24","28.49001953125","2013","基药","嘉峪关市,武威市","2","13" "安徽精方药业股份有限公司","安徽精方药业股份有限公司","33329","颈舒颗粒","颗粒剂","6g(人工牛黄)",,

"9","盒","颈舒颗粒","6g(人工牛黄)","国药准字Z20010153","9","41.0400390625","2011","基药","嘉峪关市,省直属,兰州市,酒泉市,金昌市,甘南藏族自治州","6","9","34","-3",,

,,

,,

"安徽精方药业股份有限公司","安徽精方药业股份有限公司","302198","风湿骨痛","胶囊(硬胶囊)","0.3g","双铝塑包装","80","盒","风湿骨痛胶囊","0.3g","国药准字Z34020025","80","47.3900390625","2013","基药",,

"0","15" "安徽精方药业股份有限公司","安徽精方药业股份有限公司","301513","风湿骨痛","硬胶囊","0.3g","双铝塑包装","32","盒","风湿骨痛胶囊","0.3g","国药准字Z34020025","32","19.58","2013","基药","嘉峪关市,酒泉市,甘南藏族自治州,金昌市,兰州市","5","10" "安徽九方制药有限公司","安徽九方制药有限公司","301463","六味地黄","胶囊剂","0.3g","铝塑板封装","12","盒","六味地黄胶囊","0.3g","国药准字Z34020074","12","6.3500048828125","2013","基药","平凉市","1","14","14","-3",,

下载(注:源文件不在本站服务器,都将跳转到源网站下载)
备用下载
发帖评论
相关话题
发布一个新话题